Remove tag
article thumbnail

Epigenetics discovery could lead to new class of cancer drugs

Drug Discovery World

New understanding of epigenetics It has been known for more than 20 years that the enzymes placing H3K4me3, a chemical tag added to DNA, are crucial for normal cell development, as well as being linked to leukaemia, breast, bowel and pancreatic cancers.

article thumbnail

This week in drug discovery (24-28 October)

Drug Discovery World

New research suggests messenger RNA can be effectively used as a ‘universal’ therapy against different coronaviruses. . Click’ chemistry used to tag proteins made by cancer cells . This week’s top stories: . Could mRNA become a ‘universal’ Covid-19 treatment? . Radioactive implant ‘completely eliminated’ tumours .

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

The Pharma Data

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. Similar to other enveloped RNA viruses such as HIV, RSV and Influenza, SARS-CoV-2 is also an RNA virus that has a trimeric spike (S) protein on its viral envelope.

article thumbnail

Gene Silencing Porphyria Treatment, Givlaari, Finally Wins Over England’s NICE Amid Stellar Long-Term Data

XTalks

The treatment came with an initial price tag of $39,000 per vial, which amounts to a total of $575,00 each year. Givlaari reduces ALAS1 levels through RNA interference-mediated gene silencing, which targets ALAS1 mRNA. However, Alnylam recently offered a confidential discount just before NICE’s latest recommendation came out.

article thumbnail

AI-designed protein awakens silenced genes, one by one

The Pharma Data

Cas9 binds and uses RNA as an address-tag. The system allows scientists, by synthesizing a specific “address-tagRNA, to bring Cas9 to a precise location in genome and therefore cut and splice genes at specific sites. The AI-designed blocking protein was the cargo of the dCas9-RNA construct.

Protein 52
article thumbnail

Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates

The Pharma Data

Utilizing Clover’s proprietary Trimer-Tag © technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. Similar to other enveloped RNA viruses such as HIV, RSV and Influenza, SARS-CoV-2 is also an RNA virus that has a trimeric spike (S) protein on its viral envelope. About Trimer-Tag © Technology.

article thumbnail

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

The Pharma Data

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. Similar to other enveloped RNA viruses such as HIV, RSV and Influenza, SARS-CoV-2 is also an RNA virus that has a trimeric spike (S) protein on its viral envelope.